Industry Symposium by Siemens Healthineers and Bayer

IND 3 - Advances in Breast Screening: imaging options for personalized diagnostics

Lectures

1
Advances in Breast Screening: imaging options for personalized diagnostics (Complete Session)

Advances in Breast Screening: imaging options for personalized diagnostics (Complete Session)

60:00Daan Hellingman, Den Hague / NL, Isabelle Thomassin-Naggara, Paris / FR, Adrian K. P. Lim, London / UK, Ritse Mann, Nijmegen / NL, Daniela Bernardi, Pieve Emanuele / IT

Breast screening programs have been a key topic of discussion for nearly 50 years. New findings from scientific studies combined with technological advancements continue to spark new debates. It often feels like every answered question raises two new ones.


While we may not solve the complex challenges of achieving ideal breast screening during this symposium, renowned breast radiologists will contribute to the ongoing development of personalized screening programs by sharing their experiences with current breast examination techniques:

•Breast tomosynthesis for screening average-risk women

•Contrast enhanced imaging (CEM and MRI) for intermediate and high-risk patients

•The use of super high frequency ultrasound probe

5 min
Advances in Breast Screening - Introduction
Daan Hellingman, Den Hague / Netherlands
  1. Breast tomosynthesis for screening average-risk women
  2. Contrast enhanced imaging (CEM and MRI) for intermediate and high-risk patients
  3. The use of super high frequency ultrasound probe
12 min
Rethinking Breast Cancer Follow-Up: Exploring Contrast-Enhanced Mammography as a Game-Changer
Daniela Bernardi, Pieve Emanuele / Italy
  1. Assess Current Follow-Up Practices: Gain insights into the existing imaging methods for breast cancer follow-up, understanding their strengths and limitations in post-surgical patients.
  2. Introduce CEM as an Alternative: Explore the potential of Contrast-Enhanced Mammography to address the shortcomings of traditional approaches, backed by evidence from the COMBO trial.
  3. Envision the Future of Follow-Up: Discuss how CEM could reshape breast cancer follow-up protocols, improving early detection and patient outcomes.
12 min
DBT in women with average risk
Isabelle Thomassin-Naggara, Paris / France
  1. To know the literature evidence to use DBT for breast screening
  2. To understand the main limitations that explain the absence of implementation in many countries
  3. To explore the next future with AI implementation
12 min
The clinical utility of super high frequency ultrasound probes in breast examinations – benefits and limitations
Adrian K. P. Lim, London / United Kingdom
  1. Discuss the clinical application of Siemens Healthineers’ new super high-frequency ultrasound probe, the “HLX”
  2. Compare images obtained with the conventional breast frequency probe (15 Mhz) and the HLX (> 20 Mhz)
  3. Discuss limitations of the use of this super high frequency probe
12 min
The evolving role of MRI in breast cancer screening
Ritse Mann, Nijmegen / Netherlands
  1. Review recent advances in Breast Cancer screening and International Recommendations: understand the role of Breast MRI
  2. Understand the need for Abbreviated Breast MRI
  3. Discuss innovations in Breast MRI: Ultrafast dynamic breast MRI in clinical practice and a glimpse into the future

This session offers AI-generated subtitles.